List of Tables
List of Figures
Report Guidance
GlobalData Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Hepatitis C to Infectious Disease Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Hepatitis C to Infectious Disease Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Hepatitis C Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Hepatitis C
Nov 11, 2019: Cocrystal Pharma presents positive data from U.S. phase 2a study of CC-31244 demonstrating ability to identify patients more likely to respond to ultrashort treatment of HCV
Nov 08, 2019: Gilead announces new data from viral hepatitis research programs at The Liver Meeting 2019
Oct 30, 2019: Cocrystal Pharma announces new data on CC-31244 and abstract acceptance for poster presentation at the AASLD 2019 Liver Meeting
Clinical Trial Profile Spshots
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Source